• Register
  • Login
  • Subscribe
  • Contact Us

Supply of Neostigmine Methylsolfate 0.5Mg/Ml Solution Injectable Non -Attractive Use Im and Ev 1Ml Fault (Abroad) Attention: Product of European Origin is Required, in Case of Unavailability, s ...

ItalyTenders notice for Supply of Neostigmine Methylsolfate 0.5Mg/Ml Solution Injectable Non -Attractive Use Im and Ev 1Ml Fault (Abroad) Attention: Product of European Origin is Required, in Case of Unavailability, s .... The reference ID of the tender is 118892401 and it is closing on 13 May 2025.

Tender Details

  • Country: Italy
  • Summary: Supply of Neostigmine Methylsolfate 0.5Mg/Ml Solution Injectable Non -Attractive Use Im and Ev 1Ml Fault (Abroad) Attention: Product of European Origin is Required, in Case of Unavailability, s ...
  • ITT Ref No: 118892401
  • Deadline: 13 May 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: EUR 33000
  • Notice Type: Tender
  • Document Ref. No.: BGEST-FAR_2025_75F
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Supply of neostigmine methylsolfate 0.5mg/ml injectable solution of non -attractive use IM and EV 1ml (abroad) attention: the product of European origin is required, in the event of unavailability, products of non -European origin will also be considered with attached documentation timeTo ensure that: "The product is prepared according to the quality and safety requirements equivalent to those provided for by current legislation (GMP)" as required by the AIFA module. (Procedure for total estimated total needs of 600fial/12mese - orders of maximum of 300 vials/each) - for infoTel. 035/3064372
    Product Categories: Pharmaceutical products.
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Supply of Neostigmine Methylsolfate 0.5Mg/Ml Solution Injectable Non -Attractive Use Im and Ev 1Ml Fault (Abroad) Attention: Product of European Origin is Required, in Case of Unavailability, s ... - Italy Tender

The ASST BY BERGAMO EST, a Government sector organization in Italy, has announced a new tender for Supply of Neostigmine Methylsolfate 0.5Mg/Ml Solution Injectable Non -Attractive Use Im and Ev 1Ml Fault (Abroad) Attention: Product of European Origin is Required, in Case of Unavailability, s .... This tender is published on ItalyTenders under ITT Ref No: 118892401 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-13.

The estimated tender value is EUR 33000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

ItalyTenders Features

ItalyTenders Features

Fresh and verified Tenders from Italy. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ItalyTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Italy in your email inbox.

  Chat with us